-
Results of a new survey released by the National Association of Nurse Practitioners in Women's Health (NPWH) indicate that most of the 1,000 women polled often confused myth with fact when quizzed about cervical cancer prevention.
-
Patients seeking medication abortion using mifepristone (Mifeprex, Danco Group) may be asking questions after news agencies reported leukemia drug safety issues at a Chinese drug manufacturing firm that serves as the sole U.S. supplier of mifepristone.
-
A multidrug-resistant variant of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteria is emerging in cities on both coasts of the United States, according to data from a new California-led study.
-
Federal and state funding for family planning client services reached $1.85 billion in FY 2006, a 63% increase over 12 years, adjusting for inflation.
-
-
Using a simple clinical screening tool, patients considered at high risk for death in this closed medical ICU received a basic palliative care consultation. Those with unmet needs received a full consultation with ongoing intervention from the palliative care team. This process shortened ICU length of stay without affecting mortality rates or discharge disposition.
-
Two recent studies suggest that rapid TIA evaluation and treatment can reduce stroke risk.
-
Schistosomiasis and strongyloidiasis were highly prevalent in two cohorts of African refugees resettled to the United States; presumptive treatment for parasitic diseases in such groups should include coverage for these parasitoses.
-
Of 2761 patients with endocarditis enrolled in a prospective, multinational cohort study, 49 patients with non-HACEK gram-negative endocarditis were identified. E. coli and Pseudomonas aeruginosa were the most common pathogens, and 57% were considered to be health care associated. Fifty-nine percent of cases were associated with prosthetic valves. The mortality rate was high (24%) despite cardiac surgery being performed in 51% of cases.
-
An early invasive approach is preferred for higher risk non-ST elevation acute coronary syndromes (NSTE-ACS), but the optimal timing of cardiac catheterization is not clear.
